EVISA Print | Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:

Simultaneous Speciation Analysis of Iodine-, Gadolinium-, and Platinum-Based Pharmaceuticals by HILIC-ICP-MS and Its Application to Wastewaters

(23.10.2025)


Background:
The widespread use of pharmaceuticals such as iodine-based contrast media (ICM) for medical imaging and platinum-containing anticancer agents has led to their detection in wastewater and surface waters. These substances are typically found at concentrations up to the µg L⁻¹ level for ICMs and at the ng L⁻¹ range for cancerostatic platinum compounds (CPCs) and gadolinium-based contrast agents (GBCAs). Due to their poor removal efficiency in wastewater treatment plants, these compounds have been observed to contaminate drinking water resources. Gadolinium, for example, has even been used as a tracer to monitor contaminant transfer from wastewater to drinking water systems

To investigate the release, transport, and fate of these compounds in the aquatic environment, highly sensitive analytical techniques are required. The coupling of liquid chromatography (LC) with inductively coupled plasma mass spectrometry (ICP-MS) has been widely employed for such studies, providing both elemental specificity and excellent detection limits. However, achieving simultaneous speciation of multiple classes of contrast agents remains a significant analytical challenge.

The New Study:
A research team from the University of Pau (France) has developed an analytical methodology for the simultaneous speciation of iodine-, platinum-, and gadolinium-based complexes at ultratrace concentrations (∼ng L⁻¹). This task is particularly demanding because the target compounds exhibit diverse physicochemical properties—ranging from neutral to ionic or ionizable species with varying polarities.

The scientists focused on hydrophilic interaction chromatography (HILIC) coupled with ICP-MS to separate and quantify ten pharmaceutical residues, including three iodine-, three platinum-, and four gadolinium-based complexes. 


Figure: Structure of considered pharmaceuticals


Three HILIC stationary phases were compared: two zwitterionic phases (phosphorylcholine and ammonium–sulfonic acid) and one charged silica phase. The effects of mobile phase composition (organic solvent ratio, salt concentration, and pH) were systematically investigated. Furthermore, dipole moment calculations using density functional theory (DFT) provided insight into the observed separation behavior.

The optimized method was then applied to urban and hospital wastewater samples. Two ICMs (iohexol and iopamidol) and one GBCA (gadoterate) were detected. Gadoterate concentrations were similar in both wastewater types, ranging from 525 to 677 ng L⁻¹ Gd. Iohexol was found only in urban wastewater (30 µg L⁻¹ I), while iopamidol concentrations were about 30 times lower in urban wastewater compared to hospital effluents (134 ng L⁻¹ I).

Conclusions:
This study reports, for the first time, the simultaneous separation of ten pharmaceutical residues in environmental water samples using HILIC-ICP-MS—a significant advancement for monitoring emerging contaminants in the water cycle. The authors note that future work will focus on time-series monitoring of these compounds across various wastewater sources and locations. Such studies will improve understanding of temporal and spatial concentration trends and may lead to the identification of new pharmaceutical contaminants in the aquatic environment.




The original study: 

 Joseph Côme, Maïté Bueno, Panaghiotis Karamanis, Florence Pannier, Sandra Mounicou, Simultaneous speciation of iodine-, gadolinium-, and platinum-based pharmaceuticals by HILIC-ICP-MS and its application to wastewaters, Talanta, 298 (2025) 128974. DOI: 10.1016/j.talanta.2025.128974 




 Related studies (newest first):

 M. Macke, C.D. Quarles, M. Sperling, U. Karst, Fast and automated monitoring of gadolinium-based contrast agents in surface waters, Water Res., 207 (2021) Article 117836. DOI: 10.1016/j.watres.2021.117836

 S. Okabayashi, L. Kawane, N.Y. Mrabawani, T. Iwai, T. Narukawa, M. Tsuboi, K. Chiba, Speciation analysis of Gadolinium-based contrast agents using aqueous eluent-hydrophilic interaction liquid chromatography hyphenated with inductively coupled plasma-mass spectrometry, Talanta, 222 (2021) Article 121531. DOI:  10.1016/j.talanta.2020.121531

 M. Horstmann, R. Gonzalez de Vega, David P. Bishop, U. Karst, P.A. Doble, D. Clases, Determination of gadolinium MRI contrast agents in fresh and oceanic waters of Australia employing micro-solid phase extraction, HILIC-ICP-MS and bandpass mass filtering, J. Anal. At. Spectrom., 36 (2021)767-775. DOI: 10.1039/D0JA00493F

 M. Birka, C.A. Wehe, O. Hachmöller, M. Sperling, U. Karst, Tracing gadolinium-based contrast agents from surface water to drinking water by means of speciation analysis, J. Chromatogr. A, 1440 (2016) 105-111. DOI: 10.1016/j.chroma.2016.02.050

 U. Lindner, J. Lingott, S. Richter, W. Jiang, N. Jakubowski, U. Panne, Analysis of Gadolinium-based contrast agents in tap water with a new hydrophilic interaction chromatography (ZIC-cHILIC) hyphenated with inductively coupled plasma mass spectrometry, Anal. Bioanal. Chem., 407 (2015) 2415-2422. DOI: 10.1007/s00216-014-8368-5

 J. Vidmar, A. Martinčič, R. Milačič, J. Ščančar, Speciation of cisplatin in environmental water samples by hydrophilic interaction liquid chromatography coupled to inductively coupled plasma mass spectrometry, Talanta, 138 (2015), 1-7. DOI: 10.1016/j.talanta.2015.02.008

 U. Lindner, J. Lingott, S. Richter, N. Jakubowski, U. Panne, Speciation of gadolinium in surface water samples and plants by hydrophilic interaction chromatography hyphenated with inductively coupled plasma mass spectrometry, Anal. Bioanal. Chem., 405 (2013) 1865-1873. DOI: 10.1007/s00216-012-6643-x

 M. Birka, C.A. Wehe, L. Telgmann, M. Sperling, U. Karst, Sensitive quantification of gadolinium-based magnetic resonance imaging contrast agents in surface waters using hydrophilic interaction liquid chromatography and inductively coupled plasma sector field mass spectrometry, J. Chromatogr. A, 1308 (2013) 125-131. DOI:  10.1016/j.chroma.2013.08.017

 L. Telgmann, C.A. Wehe, M. Birka, J. Künnemeyer, S. Nowak, M. Sperling, U. Karst, Speciation and isotope dilution analysis of gadolinium-based contrast agents in wastewater, Environ. Sci. Technol., 46 (2012) 11929-11936. DOI: 10.1021/es301981z

 C.S.K. Raju, A. Cossmer, H. Scharf, U. Panne, D. Lück, Speciation of gadolinium based MRI contrast agents in environmental water samples using hydrophilic interaction chromatography hyphenated with inductively coupled plasma mass spectrometry, J. Anal. At. Spectrom., 25 (2010) 55-61. DOI: 10.1039/B919959D

 J. Künnemeyer, L. Terborg, B. Meermann, C. Brauckmann, I. Möller, A. Scheffer, U. Karst, Speciation analysis of gadolinium chelates in hospital effluents and wastewater treatment plant sewage by a novel HILIC/ICP-MS method, Environ. Sci. Technol., 43 (2009) 2884-2890. DOI: 10.1021/es803278n

 S. Hann, Zs Stefánka, K. Lenz, G. Stingeder, Novel separation method for highly sensitive speciation of cancerostatic platinum compounds by HPLC-ICP-MS, Anal. Bioanal. Chem., 381 (2005), 405-412. DOI: 10.1007/s00216-004-2839-z




 Related EVISA Resources




Related EVISA News (newest first)


July 14, 2022: Ultra-sensitive speciation analysis of inorganic platinum-chloride complexes in platinum-based drugs by HPLC-ICP-MS
April 26, 2022: Interaction of gadolinium-based contrast agents with humic substances 
November 13, 2021: Fast and Automated Monitoring of Gadolinium-based Contrast Agents in Surface Waters 
February 14, 2021: Determination of gadolinium-based MRI contrast agents in fresh and oceanic waters of Australia
December 2, 2020: Speciation analysis of Gadolinium-based contrast agents using hydrophilic interaction liquid chromatography hyphenated with inductively coupled plasma-mass spectrometry by avoiding organic solvents 
October 18, 2012: The behavior of Gd-based contrast agents during wastewater treatment 
 March 25, 2010: Publication on the separation of Gd-based contrast agents awarded 
April 17, 2009: Gadolinium-based MRI contrast agents found intact in the outlet of a waste water treatment plant 


last time modified: October 23, 2025










Imprint     Disclaimer

© 2003 - 2025 by European Virtual Institute for Speciation Analysis ( EVISA )